Projects
200,000 new compounds — matched to each patient by AI
We have generated 200,000 new compounds and fast AI to select the right compound on the basis of each patient’s genomic profile — solving the lack of personalised therapeutics in this field.
Where CureLogic is making an impact
From new discovery tools to organ-on-a-chip models built with leading academic partners — here’s what we’re working on.
Project 01
New tools developed
A suite of new research tools developed by CureLogic to advance personalised, AI-driven therapeutic discovery.
Project 02
Artery-on-a-chip model
Developing a new artery-on-a-chip model to study vascular disease and validate therapeutics in a physiologically relevant system.
Project 03
Glomerulus-on-a-chip
A glomerulus-on-a-chip platform where CureLogic plays a central role in creating dedicated cells from precursor cells.
Nanokid
Kidney-on-a-chip from first principles
A major NWO-funded project building a kidney-on-a-chip from first principles. CureLogic supports the biologists in creating appropriate kidney cells from precursor cells.
One size does not fit all
Treatments that work for some may be ineffective — or even harmful — for others. Personalised medicine uses advanced data, genomics, and AI to tailor prevention and treatment to each person’s unique biology, lifestyle, and environment.
Personalised medicine is a transformative approach to healthcare where physicians use diagnostic tests and detailed individual health information to tailor treatment that works best for each patient. This involves:
- Leveraging genomic data, blood chemistry, and environmental data of the patient.
- Considering an individual’s medical history, lifestyle, and values.
- Developing targeted prevention and treatment plans in collaboration with patients.
By focusing on the unique molecular mechanisms that affect health, personalised medicine ensures more effective treatments and the ability to proactively address conditions at their source.
Personalised medicine benefits a wide range of patients by guiding them toward prevention and treatment strategies tailored to their unique needs. It is especially valuable in addressing:
- Heart diseases
- Cancers
- Genetic diseases
- Rare diseases
- Neurological diseases
By moving beyond the ‘one size fits all’ model, personalised medicine empowers patients and providers to achieve better health outcomes.
Personalised medicine enhances healthcare at every stage — prevention, diagnosis, and treatment — by focusing on each patient’s unique biological and environmental profile.
Prevention: identifies an individual’s molecular and environmental risk factors, empowering proactive steps to prevent disease before it starts.
Diagnosis: advanced diagnostic tests reveal the underlying molecular causes of disease, letting doctors pinpoint targeted options that traditional testing may miss.
Treatment: targeted therapies address the specific biological drivers of a condition — often safer, more effective, and better tolerated than one-size-fits-all approaches.
Interested in collaborating on a project?
Partner with CureLogic on the next generation of precision-medicine research.